Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation

Atsushi Hosui1, Akiko Kimura, Daisuke Yamaji

  • 1Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. hosui@gh.med.osaka-u.ac.jp

Insights

Loss of signal transducer and activator of transcription (STAT) 5 in mice leads to increased transforming growth factor-beta (TGF-beta) and STAT3 activity, promoting liver fibrosis and cancer. Restoring STAT5 function prevents tumor development.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) development mechanisms are unclear.
  • Signal transducer and activator of transcription (STAT) 5 plays a role in liver health.
  • STAT5 deficiency is linked to liver disease progression.

Purpose of the Study:

  • To elucidate the molecular link between STAT5, transforming growth factor-beta (TGF-beta), and STAT3 in liver disease.
  • To investigate the role of STAT5 in regulating TGF-beta stability and activity.
  • To determine the in vivo significance of STAT5 in carbon tetrachloride (CCl4)-induced liver injury and tumorigenesis.

Main Methods:

  • Utilized liver-specific STAT5A/B-null (STAT5-LKO) and STAT5 N-terminus deleted (STAT5-DeltaN) mouse models.
  • Administered carbon tetrachloride (CCl4) to induce liver fibrosis and tumors.
  • Performed histological analyses, Western blotting, immunoprecipitation, and immunohistochemistry.

Main Results:

  • STAT5-LKO mice exhibited liver fibrosis, elevated TGF-beta protein levels, and increased STAT3 activity upon CCl4 treatment.
  • STAT5 deficiency enhanced mature TGF-beta protein stability without altering mRNA levels.
  • STAT5 directly binds to TGF-beta via its N-terminal domain, and its absence promotes CCl4-induced liver fibrosis but not tumors in STAT5-DeltaN mice.

Conclusions:

  • Loss of STAT5 leads to elevated TGF-beta levels and enhanced STAT3 activity.
  • A deregulated STAT5-TGF-beta-STAT3 signaling network contributes to chronic liver disease and hepatocellular carcinoma development.
  • STAT5's N-terminal domain is crucial for preventing CCl4-induced liver tumorigenesis.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...